| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs494562 |
inosine |
A/G |
2639 |
0.9 |
-0.118 (0.017) |
1.34·10-12 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs494562 |
| Chromosomal location | Chr6: 86,173,848 (6q14.3) |
| Gene (distance) | NT5E (-42,172) |
| Predicted causal gene | NT5E |
| Gene/protein classification | - |
| Metabolite (Pathway) | inosine (Purine metabolism, (hypo)xanthine, inosine containing; Nucleotide) |
| Biochemical locus-metabolite relationship | NT5E encodes an ecto 5'-nucleotidase which can generate inosine as a product [6271180]. |
| eQTL associations | NT5E (L) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | inosine [21886157] |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | CHEMBL5957 |
| Drug information |
Compounds with inhibitory activity in ChEMBL
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |